Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy of Linaclotide in Patients With Chronic Constipation and Prominent Abdominal Bloating

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Patient has completed a colonoscopy according to the American Gastroenterological Association criteria with no clinically significant findings~* Patient has successfully completed protocol procedures (with no clinically significant findings)~* Patient meets protocol criteria for Chronic Constipation(CC): \< 3 bowel movements per week and reports one or more of the following symptoms for at least 12 weeks:~  1. Straining during more than 25% of BMs~ 2. Lumpy or hard stools during more than 25% of BMs~ 3. Sensation of incomplete evacuation during more than 25% of BMs~* Patient demonstrates continued chronic constipation and bloating through Pretreatment Period~* Patient is compliant with Interactive voice response System (IVRS)~Exclusion Criteria:~* Patient has a history of loose or watery stools~* Patient has symptoms of or been diagnosed with Irritable Bowel Syndrome (IBS)~* Patient has a structural abnormality of the gastrointestinal (GI) tract or a disease or condition that can affect GI motility~* Patient has any protocol-excluded or clinically significant medical or surgical history that would limit the patient's ability to complete or participate in this clinical trial or could confound the study assessments

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Linaclotide 290 micrograms (Type: EXPERIMENTAL): Linaclotide 290 micrograms
- Linaclotide 145 Micrograms (Type: EXPERIMENTAL): Linaclotide 145 micrograms
- Placebo (Type: PLACEBO_COMPARATOR): Matching placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).